News Daily News Social Factors Contribute to Race Differences in Premature CVD: CARDIA Yael L. Maxwell May 30, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Conference News EAS 2022 Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol Michael O'Riordan May 26, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News Coronary Plaque Seen in Half of Asymptomatic Individuals on CTA Yael L. Maxwell May 16, 2022
News Daily News New CAC Risk Tool Helps Contextualize Scores for Younger Adults Yael L. Maxwell May 12, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows Michael O'Riordan May 04, 2022
News Daily News For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains Michael O'Riordan May 03, 2022
News Daily News FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars Michael O'Riordan April 28, 2022
News Daily News Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey Caitlin E. Cox April 26, 2022
News Daily News USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention Shelley Wood April 26, 2022
News Daily News CVD Hospitalizations Spiked in Aftermath of 2020 US Election Michael O'Riordan April 22, 2022
News Conference News ACC 2022 Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70 Michael O'Riordan April 07, 2022
Presentation ACC 2022 A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen April 04, 2022